Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2000

View Archived Issues

KF-20444 has potent immunosuppressive activity

Alexion signs transgenic agreement with Genzyme Transgenics

Ligand sells Marathon assets to CoPharma

Lexicon Genetics and Scripps Institute announce functional genomics agreement

Ares-Serono and Alkermes to collaborate on sustained-release formulations of proteins

INDs filed by Anesta for two OTS products

Access files IND for amlexanox oral rinse

Genset and Whitehead Institute collaborate on obesity and diabetes research

Cephalon compounds enhance spinal cord ChAT activity, inhibit kinase activity

Carbapenems synthesized at Merck active against resistant Gram-positive bacteria

PDH activators with benzenesulfonamide structure designed at AstraZeneca

Vertex continues to pursue therapeutically active p38 MAP kinase inhibitors

Esteve presents new COX-2 inhibitor and pharmacological profile

Selective GABA-A alpha5 receptor inverse agonists useful for cognitive impairment

Schering AG expands its presence in Japan

Novo Nordisk demerger: company names, logos revealed

New twist in the mergers saga: Warner-Lambert pursues discussions with Pfizer

Antex creates new antibiotics to combat antibiotic-resistant bacteria

OrthoLogic initiates phase I/II trial of Chrysalin for accelerated tissue repair

Remaking the pharmaceutical industry: two other heavyweights now in merger discussions

Significant progress made in continuing trials of Oralgen/Oralin

Antiobesity effects of LEP-(116-130) do not involve interaction with leptin receptors

Health Canada grants priority review to Vanlev

Carrington completes enrollment for phase III trial of ulcerative colitis treatment

FDA accepts NDA for new Rapamune formulation

Mechanism of MDR reversal by TER-199 under investigation

AltaRex in-licenses antibody from NIH for AIT platform

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...